REATA PHARMACEUTICALS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Reata Pharmaceuticals, Inc. - RETA

This action is pending in the United States District Court for the Eastern District of Texas.